Serial #98902079
LIVE

Serial Number

98902079

Owner

Eikon Therapeutics, Inc.

Attorney

Anna E. Raimer

Filing Date

Dec 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98902079 Trademark

Serial Number: 98902079

Serial #98902079 is a trademark filed by Eikon Therapeutics, Inc. on December 13, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 37 (Building & Construction), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

Eikon Therapeutics, Inc. (10 trademarks)

3929 Point Eden Way
Hayward, CA 94545

Entity Type: 03

Trademark Details

Filing Date

December 13, 2024

Registration Date

Not Registered

Published for Opposition

September 16, 2025

Goods & Services

Installation services for fluorescence microscopes and recorded operating software sold as a unit therewith; maintenance services for fluorescence microscopes containing embedded hardware and recorded software

Fluorescence microscopes and instruction manuals sold therewith; Parts and fittings for fluorescence microscopes; Recorded operating software sold as a unit with fluorescence microscopes for analyzing and reporting scientific and biological research in the fields of pharmaceuticals, agriculture, and material sciences; accessories for microscopes, namely, stage plates, sample chambers, and slide wells, all the foregoing for conducting scientific and biological research in the fields of pharmaceuticals, agriculture, and material sciences; Downloadable software for analyzing and reporting scientific and biological research in the fields of pharmaceuticals, agriculture, and material sciences

Pharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals, and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; vaccines; Pharmaceutical preparations for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; Biopharmaceuticals in the nature of pharmaceutical preparations for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; Therapeutic pharmaceuticals for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; diagnostic substances, preparations, and agents for medical purposes

fluorescent agents, and kits comprised of fluorescent dyes, reagents, chemical assays, and also containing living cells, all the foregoing for conducting scientific and biological research in the fields of pharmaceuticals, agriculture, and material sciences

Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industries; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and development; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development services; Drug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testing; Research and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicines; Biomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Medical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Research, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticals; Scientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Scientific laboratory services, namely, live cell imaging analysis; Custom design and development of cells, cell lines and assays; Biomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and development; Providing a website featuring information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals; Provision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trials; Providing a website featuring technology that allows users to conduct drug discovery and development; Providing a website featuring technology that allows users to track and measure movement of proteins in living cells; Software as a service (SAAS) services featuring software for analyzing and reporting scientific and biological research in the fields of pharmaceuticals, agriculture, and material sciences; Providing a website featuring technology that enables users to conduct scientific and biological research in the fields of pharmaceuticals, agriculture, and material sciences, and report the results of such research; Consulting services in connection with the use of fluorescence microscopes for conducting and reporting scientific and biological research in the fields of pharmaceuticals, agriculture, and material sciences; High-throughput screening services for chemical compounds for scientific research purposes, in the fields of pharmaceuticals, agriculture, and material sciences; Custom design and development of living cells, human cell lines, fluorescent dyes, reagents, chemical assays, namely, fluorescent agents, pre-treated and untreated plates, and kits, all the foregoing for use in conducting scientific and biological research in the fields of pharmaceuticals, agriculture, and material sciences; Super-resolution microscopy services for conducting scientific and biological research in the fields of pharmaceutical, agricultural, and material sciences

Licensing of computer software for use with fluorescence microscopes

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 24, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 24, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 24, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 24, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 26, 2026 EXRA
SOU EXTENSION 1 GRANTED
Feb 25, 2026 EX1G
SOU EXTENSION 1 FILED
Feb 25, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 25, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 10, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 19, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 19, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 19, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 19, 2025 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 25, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 25, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 25, 2025 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 17, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 17, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 17, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 27, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2025 NWOS
NEW APPLICATION ENTERED
Dec 13, 2024 NWAP